位置:首页 > 蛋白库 > ADPRS_LATCH
ADPRS_LATCH
ID   ADPRS_LATCH             Reviewed;         356 AA.
AC   H3BCW1;
DT   13-FEB-2019, integrated into UniProtKB/Swiss-Prot.
DT   18-APR-2012, sequence version 1.
DT   03-AUG-2022, entry version 48.
DE   RecName: Full=ADP-ribosylhydrolase ARH3 {ECO:0000305};
DE   AltName: Full=ADP-ribose glycohydrolase ARH3 {ECO:0000305};
DE            Short=LchARH3 {ECO:0000303|PubMed:30472116};
DE   AltName: Full=ADP-ribosylhydrolase 3 {ECO:0000250|UniProtKB:Q9NX46};
DE   AltName: Full=O-acetyl-ADP-ribose deacetylase ARH3 {ECO:0000305};
DE            EC=3.5.1.- {ECO:0000250|UniProtKB:Q9NX46};
DE   AltName: Full=Poly(ADP-ribose) glycohydrolase ARH3 {ECO:0000305};
DE            EC=3.2.1.143 {ECO:0000269|PubMed:30472116};
DE   AltName: Full=[Protein ADP-ribosylarginine] hydrolase-like protein 2 {ECO:0000305};
DE   AltName: Full=[Protein ADP-ribosylserine] hydrolase;
DE            EC=3.2.2.-;
GN   Name=adprs;
GN   Synonyms=adprhl2 {ECO:0000312|Ensembl:ENSLACP00000019732},
GN   arh3 {ECO:0000303|PubMed:30472116};
OS   Latimeria chalumnae (Coelacanth).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Coelacanthiformes; Coelacanthidae; Latimeria.
OX   NCBI_TaxID=7897;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=9215903; DOI=10.1093/genetics/146.3.995;
RA   Zardoya R., Meyer A.;
RT   "The complete DNA sequence of the mitochondrial genome of a 'living
RT   fossil,' the coelacanth (Latimeria chalumnae).";
RL   Genetics 146:995-1010(1997).
RN   [2]
RP   X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) OF 10-356 IN COMPLEX WITH MAGNESIUM
RP   AND ADP-RIBOSE, FUNCTION, CATALYTIC ACTIVITY, COFACTOR, ACTIVITY
RP   REGULATION, AND MUTAGENESIS OF GLU-33; ASP-63; ASP-64; ASP-303 AND ASP-305.
RX   PubMed=30472116; DOI=10.1016/j.chembiol.2018.11.001;
RA   Rack J.G.M., Ariza A., Drown B.S., Henfrey C., Bartlett E., Shirai T.,
RA   Hergenrother P.J., Ahel I.;
RT   "(ADP-ribosyl)hydrolases: Structural Basis for Differential Substrate
RT   Recognition and Inhibition.";
RL   Cell Chem. Biol. 0:0-0(2018).
RN   [3] {ECO:0007744|PDB:7AQM}
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 10-356 IN COMPLEX WITH
RP   METHYL-ADP-RIBOSE.
RX   PubMed=34321462; DOI=10.1038/s41467-021-24723-3;
RA   Rack J.G.M., Liu Q., Zorzini V., Voorneveld J., Ariza A.,
RA   Honarmand Ebrahimi K., Reber J.M., Krassnig S.C., Ahel D.,
RA   van der Marel G.A., Mangerich A., McCullagh J.S.O., Filippov D.V., Ahel I.;
RT   "Mechanistic insights into the three steps of poly(ADP-ribosylation)
RT   reversal.";
RL   Nat. Commun. 12:4581-4581(2021).
CC   -!- FUNCTION: ADP-ribosylhydrolase that preferentially hydrolyzes the
CC       scissile alpha-O-linkage attached to the anomeric C1'' position of ADP-
CC       ribose and acts on different substrates, such as proteins ADP-
CC       ribosylated on serine and threonine, free poly(ADP-ribose) and O-
CC       acetyl-ADP-D-ribose (PubMed:30472116). Specifically acts as a serine
CC       mono-ADP-ribosylhydrolase by mediating the removal of mono-ADP-ribose
CC       attached to serine residues on proteins, thereby playing a key role in
CC       DNA damage response (PubMed:30472116). Serine ADP-ribosylation of
CC       proteins constitutes the primary form of ADP-ribosylation of proteins
CC       in response to DNA damage (By similarity). Does not hydrolyze ADP-
CC       ribosyl-arginine, -cysteine, -diphthamide, or -asparagine bonds (By
CC       similarity). Also able to degrade protein free poly(ADP-ribose), which
CC       is synthesized in response to DNA damage: free poly(ADP-ribose) acts as
CC       a potent cell death signal and its degradation by ADPRHL2 protects
CC       cells from poly(ADP-ribose)-dependent cell death, a process named
CC       parthanatos (PubMed:30472116). Also hydrolyzes free poly(ADP-ribose) in
CC       mitochondria (By similarity). Specifically digests O-acetyl-ADP-D-
CC       ribose, a product of deacetylation reactions catalyzed by sirtuins (By
CC       similarity). Specifically degrades 1''-O-acetyl-ADP-D-ribose isomer,
CC       rather than 2''-O-acetyl-ADP-D-ribose or 3''-O-acetyl-ADP-D-ribose
CC       isomers (By similarity). {ECO:0000250|UniProtKB:Q9NX46,
CC       ECO:0000269|PubMed:30472116}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=[(1''->2')-ADP-alpha-D-ribose](n) + H2O = [(1''->2')-ADP-
CC         alpha-D-ribose](n-1) + ADP-D-ribose; Xref=Rhea:RHEA:52216, Rhea:RHEA-
CC         COMP:16922, Rhea:RHEA-COMP:16923, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:57967, ChEBI:CHEBI:142512; EC=3.2.1.143;
CC         Evidence={ECO:0000269|PubMed:30472116};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52217;
CC         Evidence={ECO:0000269|PubMed:30472116};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1''-O-acetyl-ADP-alpha-D-ribose + H2O = acetate + ADP-D-ribose
CC         + H(+); Xref=Rhea:RHEA:58112, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30089, ChEBI:CHEBI:57967, ChEBI:CHEBI:142511;
CC         Evidence={ECO:0000250|UniProtKB:Q9NX46};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-(ADP-D-ribosyl)-L-seryl-[protein] = ADP-D-ribose + L-
CC         seryl-[protein]; Xref=Rhea:RHEA:58256, Rhea:RHEA-COMP:9863,
CC         Rhea:RHEA-COMP:15091, ChEBI:CHEBI:15377, ChEBI:CHEBI:29999,
CC         ChEBI:CHEBI:57967, ChEBI:CHEBI:142556;
CC         Evidence={ECO:0000269|PubMed:30472116};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=alpha-NAD(+) + H2O = ADP-D-ribose + H(+) + nicotinamide;
CC         Xref=Rhea:RHEA:68792, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17154, ChEBI:CHEBI:57967, ChEBI:CHEBI:77017;
CC         Evidence={ECO:0000250|UniProtKB:Q9NX46};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:30472116};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000305|PubMed:30472116};
CC       Note=Binds 2 magnesium ions per subunit. {ECO:0000269|PubMed:30472116};
CC   -!- ACTIVITY REGULATION: The protein undergoes a dramatic conformational
CC       switch from closed to open states upon substrate-binding, which enables
CC       specific substrate recognition for the 1''-O-linkage (By similarity).
CC       The glutamate flap (Glu-33) blocks substrate entrance to Mg(2+) in the
CC       unliganded closed state (By similarity). In presence of substrate, Glu-
CC       33 is ejected from the active site: this closed-to-open transition
CC       significantly widens the substrate-binding channel and precisely
CC       positions the scissile 1''-O-linkage for cleavage while securing
CC       tightly 2'- and 3'-hydroxyls of ADP-ribose (By similarity). Activity is
CC       inhibited by calcium (PubMed:30472116). {ECO:0000250|UniProtKB:Q9NX46,
CC       ECO:0000269|PubMed:30472116}.
CC   -!- SUBUNIT: Monomer. {ECO:0000250|UniProtKB:Q9NX46}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q9NX46}. Cytoplasm
CC       {ECO:0000250|UniProtKB:Q9NX46}. Chromosome
CC       {ECO:0000250|UniProtKB:Q9NX46}. Mitochondrion matrix
CC       {ECO:0000250|UniProtKB:Q9NX46}. Note=Recruited to DNA lesion regions
CC       following DNA damage; ADP-D-ribose-recognition is required for
CC       recruitment to DNA damage sites. {ECO:0000250|UniProtKB:Q9NX46}.
CC   -!- SIMILARITY: Belongs to the ADP-ribosylglycohydrolase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AFYH01014263; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AFYH01014264; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_005988572.1; XM_005988510.2.
DR   PDB; 6G1P; X-ray; 1.55 A; A/B=10-356.
DR   PDB; 6G1Q; X-ray; 2.10 A; A/B=10-356.
DR   PDB; 6HGZ; X-ray; 1.86 A; A/B=10-356.
DR   PDB; 6HH3; X-ray; 1.82 A; A/B=10-356.
DR   PDB; 6HH4; X-ray; 1.66 A; A/B=10-356.
DR   PDB; 6HH5; X-ray; 1.95 A; A/B=10-356.
DR   PDB; 6HOZ; X-ray; 1.77 A; A/B=10-356.
DR   PDB; 7AQM; X-ray; 2.50 A; A/B=10-356.
DR   PDBsum; 6G1P; -.
DR   PDBsum; 6G1Q; -.
DR   PDBsum; 6HGZ; -.
DR   PDBsum; 6HH3; -.
DR   PDBsum; 6HH4; -.
DR   PDBsum; 6HH5; -.
DR   PDBsum; 6HOZ; -.
DR   PDBsum; 7AQM; -.
DR   AlphaFoldDB; H3BCW1; -.
DR   SMR; H3BCW1; -.
DR   STRING; 7897.ENSLACP00000019731; -.
DR   Ensembl; ENSLACT00000019870; ENSLACP00000019732; ENSLACG00000017349.
DR   GeneID; 102353686; -.
DR   KEGG; lcm:102353686; -.
DR   CTD; 54936; -.
DR   GeneTree; ENSGT00390000015369; -.
DR   HOGENOM; CLU_024566_6_0_1; -.
DR   OrthoDB; 988788at2759; -.
DR   Proteomes; UP000008672; Unassembled WGS sequence.
DR   Bgee; ENSLACG00000017349; Expressed in chordate pharynx and 6 other tissues.
DR   GO; GO:0005694; C:chromosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005759; C:mitochondrial matrix; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0004649; F:poly(ADP-ribose) glycohydrolase activity; IDA:UniProtKB.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW.
DR   GO; GO:0060546; P:negative regulation of necroptotic process; ISS:UniProtKB.
DR   GO; GO:0140290; P:peptidyl-serine ADP-deribosylation; IDA:UniProtKB.
DR   Gene3D; 1.10.4080.10; -; 1.
DR   InterPro; IPR005502; Ribosyl_crysJ1.
DR   InterPro; IPR036705; Ribosyl_crysJ1_sf.
DR   Pfam; PF03747; ADP_ribosyl_GH; 1.
DR   SUPFAM; SSF101478; SSF101478; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Chromosome; Cytoplasm; DNA damage; DNA repair; Hydrolase;
KW   Magnesium; Metal-binding; Mitochondrion; Nucleus; Reference proteome.
FT   CHAIN           1..356
FT                   /note="ADP-ribosylhydrolase ARH3"
FT                   /id="PRO_5003580722"
FT   BINDING         26
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:34321462,
FT                   ECO:0007744|PDB:7AQM"
FT   BINDING         33
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:30472116,
FT                   ECO:0000269|PubMed:34321462, ECO:0007744|PDB:7AQM"
FT   BINDING         62
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:30472116"
FT   BINDING         63
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:30472116,
FT                   ECO:0000269|PubMed:34321462, ECO:0007744|PDB:7AQM"
FT   BINDING         63
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:30472116"
FT   BINDING         64
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:30472116,
FT                   ECO:0000269|PubMed:34321462, ECO:0007744|PDB:7AQM"
FT   BINDING         132..138
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:30472116"
FT   BINDING         168
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:30472116"
FT   BINDING         260
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:30472116"
FT   BINDING         303
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:30472116,
FT                   ECO:0000269|PubMed:34321462, ECO:0007744|PDB:7AQM"
FT   BINDING         305
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:30472116,
FT                   ECO:0000269|PubMed:34321462, ECO:0007744|PDB:7AQM"
FT   BINDING         305
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:30472116,
FT                   ECO:0000269|PubMed:34321462, ECO:0007744|PDB:7AQM"
FT   BINDING         306
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:30472116"
FT   SITE            33
FT                   /note="Glutamate flap"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NX46"
FT   MUTAGEN         33
FT                   /note="E->Q: Complete loss of activity."
FT                   /evidence="ECO:0000269|PubMed:30472116"
FT   MUTAGEN         63
FT                   /note="D->N: Complete loss of activity."
FT                   /evidence="ECO:0000269|PubMed:30472116"
FT   MUTAGEN         64
FT                   /note="D->N: Complete loss of activity."
FT                   /evidence="ECO:0000269|PubMed:30472116"
FT   MUTAGEN         303
FT                   /note="D->N: Complete loss of activity."
FT                   /evidence="ECO:0000269|PubMed:30472116"
FT   MUTAGEN         305
FT                   /note="D->N: Complete loss of activity."
FT                   /evidence="ECO:0000269|PubMed:30472116"
FT   HELIX           12..29
FT                   /evidence="ECO:0007829|PDB:6G1P"
FT   HELIX           30..32
FT                   /evidence="ECO:0007829|PDB:6G1P"
FT   HELIX           40..52
FT                   /evidence="ECO:0007829|PDB:6G1P"
FT   STRAND          54..56
FT                   /evidence="ECO:0007829|PDB:6G1P"
FT   HELIX           63..77
FT                   /evidence="ECO:0007829|PDB:6G1P"
FT   HELIX           83..96
FT                   /evidence="ECO:0007829|PDB:6G1P"
FT   HELIX           106..114
FT                   /evidence="ECO:0007829|PDB:6G1P"
FT   STRAND          115..117
FT                   /evidence="ECO:0007829|PDB:6HH4"
FT   HELIX           123..131
FT                   /evidence="ECO:0007829|PDB:6G1P"
FT   HELIX           138..141
FT                   /evidence="ECO:0007829|PDB:6G1P"
FT   HELIX           144..149
FT                   /evidence="ECO:0007829|PDB:6G1P"
FT   HELIX           153..165
FT                   /evidence="ECO:0007829|PDB:6G1P"
FT   HELIX           171..187
FT                   /evidence="ECO:0007829|PDB:6G1P"
FT   STRAND          189..191
FT                   /evidence="ECO:0007829|PDB:6HH5"
FT   HELIX           194..209
FT                   /evidence="ECO:0007829|PDB:6G1P"
FT   HELIX           230..243
FT                   /evidence="ECO:0007829|PDB:6G1P"
FT   STRAND          244..246
FT                   /evidence="ECO:0007829|PDB:6G1P"
FT   HELIX           249..255
FT                   /evidence="ECO:0007829|PDB:6G1P"
FT   STRAND          259..261
FT                   /evidence="ECO:0007829|PDB:6G1P"
FT   HELIX           262..264
FT                   /evidence="ECO:0007829|PDB:6G1P"
FT   HELIX           266..275
FT                   /evidence="ECO:0007829|PDB:6G1P"
FT   HELIX           289..299
FT                   /evidence="ECO:0007829|PDB:6G1P"
FT   HELIX           304..319
FT                   /evidence="ECO:0007829|PDB:6G1P"
FT   HELIX           321..323
FT                   /evidence="ECO:0007829|PDB:6G1P"
FT   HELIX           326..329
FT                   /evidence="ECO:0007829|PDB:6G1P"
FT   HELIX           335..352
FT                   /evidence="ECO:0007829|PDB:6G1P"
SQ   SEQUENCE   356 AA;  38819 MW;  72731420F3F2CB80 CRC64;
     MSAVGRLAAV SLAQVRGALC GALLGDCMGA EFEGSDAVEL PDVLEFVRLL EKEKKAGTLF
     YTDDTAMTRA VIQSLIAKPD FDEVDMAKRF AEEYKKEPTR GYGAGVVQVF KKLLSPKYSD
     VFQPAREQFD GKGSYGNGGA MRVASIALAY PNIQDVIKFA RRSAQLTHAS PLGYNGAILQ
     ALAVHFALQG ELKRDTFLEQ LIGEMERIEG GEMSASDAGE HDRPNEVKLP FCSRLKKIKE
     FLASSNVPKA DIVDELGHGI AALESVPTAI YSFLHCMESD PDIPDLYNNL QRTIIYSISL
     GGDTDTIATM AGAIAGAYYG MDQVTPSWKR SCEAIVETEE SAVKLYELYC KQLKTP
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024